“Beyond PD-1 PD-L1: TME-Targeted Therapies in the Era of Immunotherapy Resistance”. Journal of Biomolecules, Pathogenesis and Therapeutics 2, no. 1 (March 10, 2026): 1–3. Accessed June 2, 2026. https://jbptjournal.org/index.php/jbpt/article/view/33.